MTOR and myeloid sarcoma: Wnt-signaling pathway (especially β-catenin, Wnt3a and APC protein expression),9 JAK/STAT signaling pathway,10 NF-kB signaling pathway11 and PImT3K/Akt/mTOR pathway12 are highly expressed in MS lesions.